Compare GoPro Inc (GPRO) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GoPro Inc vs Oruka Therapeutics Inc. Common Stock — how do they compare? GoPro Inc trades at $1.08 (market cap $238.34M), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B). The key difference: Oruka Therapeutics Inc. Common Stock is far larger — about 21.3× GoPro Inc's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, GoPro Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold GoPro Inc for 45 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| GPRO | ORKA | |
|---|---|---|
Market Cap | $238.34M | $5.08B |
Volume | 5,242,039 | 685,276 |
Sector | Technology | Health |
52-Week High | $2.31 | $113.08 |
52-Week Low | $0.58 | $26.19 |
Typical Hold Time | 45 Days | 0 Days |
Enterprise Value | $297.12M | $4.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GoPro (GPRO) trades at $1.18, down 0.84% on the day, following recent volatility driven by merger speculation and influencer investment. The stock shows bullish technical signals with oversold RSI conditions, while fundamentals reveal persistent challenges with negative net income margins (-28.52%) and declining revenue trends from $1.1B in 2022 to $652M in 2025. The company announced a $285 million merger with Starman Optical and received 11 industry awards for its MISSION 1 series, providing potential catalysts amid ongoing financial struggles.
Investment outlook remains highly speculative with significant execution risks. The merger offers potential upside but faces shareholder litigation over valuation concerns. Analyst consensus shows cautious sentiment with only 21% buy ratings, while cash flow deficits and competitive pressures from smartphone technology create substantial headwinds for sustainable recovery.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About GoPro Inc
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
